$JBSS

Trail mix and nuts recalled over potential salmonella contamination

John B. Sanfilippo & Son, Inc. has issued a voluntary recall for various trail mix and nut products, including some sold at Target, due to potential Salmonella contamination from a dry milk powder used as seasoning. Although no Salmonella has been detected in the seasoning and no illnesses have been reported, the recall is a precautionary measure. Consumers are advised to dispose of the products or return them for a refund, and aware of Salmonella symptoms, which can be severe for vulnerable populations.

Original reporting
WTVR.com · Scripps News Group
Published May 8, 2026, 2:34 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 8, 2026, 3:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Trail mix and nuts recalled over potential salmonella contamination — source image
Decision brief

The 30-second read

$JBSSBearishMed
01

Why it matters

While no illnesses have been reported, the recall raises concerns about food safety standards and company reputation.

02

Market read

The recall affects companies directly involved in the production and distribution of the contaminated products, with potential ripple effects in the retail and consumer staples sectors.

03

What to watch

Potential supply chain improvements and safety protocols could mitigate future risks, supporting long-term stability.

Timing: Immediate, as news is recent and recall is ongoing.

Background

Recent recall due to potential Salmonella contamination from dry milk powder used as seasoning in trail mix and nuts.

Company-level read

Ticker impact

$JBSSBearishHigh confidence
Context

High relevance due to direct impact on company's product safety and reputation.

Expected impact

Moderate decline of approximately 2-4% in the next trading session.

Evidence & confidence

The recall directly affects product perception and could lead to sales decline, especially if consumer confidence drops.

$TGTNeutralMedium confidence
Context

Moderate relevance as the retailer is a distributor of the affected products.

Expected impact

Minimal movement, less than 1% change expected.

Evidence & confidence

The impact is indirect and likely limited to short-term fluctuations.

Market effects

Potential negative impact on the consumer staples and retail sectors due to safety concerns.

Limited to North American markets where the products are sold.

Negligible, as the recall is localized.

Counterpoint

The recall may have limited long-term impact if the company manages the crisis effectively and consumer trust is restored.

Key entities

  • John B. Sanfilippo & Son, Inc.

    Manufacturer of trail mix and nuts.

  • Target

    Distributor of affected products.

Related articles

$AMZNMed

NYC Mayor Zohran Mamdani Sends Cease-and-Desist Letters to Amazon, Target Over E-Bikes

NYC Mayor Zohran Mamdani sent cease-and-desist letters to about 40 retailers, including Amazon, Target, Walmart, Wayfair and Temu, demanding they stop selling motorized scooters and e-bikes he says violate city law. The letters cite speed and wattage limits and require VINs. Noncompliance could bring fines up to $2,000 per sale, starting Aug. 18. Amazon said it is reviewing products.

$PGMed

Drugmakers, retailers must face ’maximum strength’ claim in decongestant false ad litigation in US

Nasdaq sees best day in over a month as Microsoft breathes life back into AI trade By Jonathan Stempel NEW YORK, July 30 (Reuters) - A federal appeals court on Thursday revived portions of nationwide litigation in which consumers accused drugmakers such as Procter & Gamble and retailers such as CVS of selling billions of dollars of over-the-counter decongestants that didn’t work. The litigation comprised about 100 lawsuits filed after a U.S.

$TGTMedAI 8/10

Target (TGT) Stock Is Up, What You Need To Know

Target shares rose about 3.4% to close at $134.12 after Wolfe Research upgraded TGT to Outperform from Peer Perform, named it a Top Pick into year-end, and set a $162 price target (~25% upside). Wolfe cited improving store performance and positive customer trends, raising 2026 EPS to $8.48 and 2027 to $9.52. Target also announced a multi-season Hollister partnership.